Skip to content

Stereotaxis STXS Gross Profit

Gross Profit at other companies

Abbott logo
AbbottABT
$6.27B+6.5%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Stryker logo
StrykerSYK
$3.81B+1.8%
ITG
Integer HoldingsITGR
$109.6M-8.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$184.8M+7.4%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Calculated from Stereotaxis’s reported figures.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's gross profit?
Stereotaxis (STXS) reported gross profit of $3.79M in Q1 2026.
How has Stereotaxis's gross profit changed year-over-year?
Stereotaxis's gross profit decreased by 6.6% year-over-year, from $4.06M to $3.79M.
What is the long-term trend for Stereotaxis's gross profit?
Over 4 years (2021 to 2025), Stereotaxis's gross profit has grown at a -7.4% compound annual growth rate (CAGR), from $23.23M to $17.07M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.